|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
0.70/-0.94
|
企业价值
122.63M
|
资产负债 |
每股账面净值
6.37
|
现金流量 |
现金流量率
0.10
|
损益表 |
收益
380.79M
|
每股收益
2.83
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/04/28 20:21 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder. |